Federation Des Caisses Desjardins Du Quebec Gossamer Bio, Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.4 Billion
- Q4 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 750 shares of GOSS stock, worth $975. This represents 0.0% of its overall portfolio holdings.
Number of Shares
750
Previous 750
-0.0%
Holding current value
$975
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding GOSS
# of Institutions
116Shares Held
163MCall Options Held
821KPut Options Held
557K-
Octagon Capital Advisors LP New York, NY18.4MShares$23.9 Million3.68% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$23.5 Million1.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$13 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL8.81MShares$11.5 Million0.03% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$10.5 Million4.56% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $122M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...